AWM
NVCT icon

Austin Wealth Management’s Nuvectis Pharma NVCT Stock Holding History

Austin Wealth Management’s Portfolio NVCT Stock Details NVCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$385K Hold
20,125
– – 0.08% 90
2026
Q1 		$154K Hold
20,125
– – 0.04% 117
2025
Q4 		$178K Hold
20,125
– – 0.03% 161
2025
Q3 		$119K Hold
20,125
– – 0.02% 159
2025
Q2 		$140K Sell
20,125
-20,125
-50% -$183K 0.02% 136
2025
Q1 		$441K Buy
+40,250
New +$290K 0.09% 82

Other funds holding NVCT

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $193M AUM 233.09% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
BWP
Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return

Austin Wealth Management's NVCT Position: Q2 2026 in Review

Austin Wealth Management held its Nuvectis Pharma (NVCT) position steady in Q2 2026 at 20,125 shares worth $385K. The position accounts for 0.08% of the portfolio, ranked #90.

Austin Wealth Management first reported a position in NVCT in Q1 2025 and has held it in 6 quarters since. The position peaked at $441K in Q1 2025. 83 funds tracked by Wall St. Rank hold NVCT as of Q2 2026.

  • Austin Wealth Management held 20,125 shares of Nuvectis Pharma worth $385K as of Q2 2026.
  • Austin Wealth Management left its Nuvectis Pharma share count unchanged in Q2 2026.
  • Nuvectis Pharma made up 0.08% of Austin Wealth Management's portfolio in Q2 2026, its #90 holding.
  • Austin Wealth Management first reported a position in Nuvectis Pharma in Q1 2025 and has held it in 6 quarters since.
  • Austin Wealth Management's Nuvectis Pharma position peaked at $441K in Q1 2025.
  • 83 funds tracked by Wall St. Rank held Nuvectis Pharma as of Q2 2026.

Based on Austin Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.